Literature DB >> 26003265

Informed consent for live liver donors: A qualitative, prospective study.

Elisa J Gordon1, Jillian Rodde2, Anton Skaro3, Talia Baker3.   

Abstract

BACKGROUND & AIMS: Adult-to-adult live donor liver transplantation (LDLT) poses serious health risks and no direct health benefits to donors. Ensuring live donors' autonomy through informed consent is critical. We assessed live liver donors' (LD) comprehension, information needs, risk perceptions, and demographics.
METHODS: Semi-structured interviews were prospectively conducted with LDs after completing donor evaluation and informed consent at our transplant center. Likert scales measured informed consent domains. Open-ended responses underwent thematic analysis.
RESULTS: Thirty LDs participated (100% participation rate). Although 90% of LDs reported being informed about donation 'a great deal', only 66% reported understanding information about donation 'a great deal.' Many (40%) reported difficulty understanding medical terminology. Information LDs most desired to feel comfortable with their decision included: incidence and type of donor complications (67%), description of donation procedure (57%), and the process of donor preparation (43%). Most (83%) LDs rated risks to themselves as 'not at all' to 'somewhat' risky, and minimized these risks.
CONCLUSIONS: Although LDs perceived that they were adequately informed, their actual comprehension about donation was inadequate. Findings suggest the value of informed consent for preparation for the procedure and potential periprocedural risks rather than for decision-making. More comprehensible information disclosure may optimize informed consent.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioethics; Education; Information needs; Informed consent; Liver transplantation; Qualitative research; Risk communication

Mesh:

Year:  2015        PMID: 26003265     DOI: 10.1016/j.jhep.2015.05.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Liver Living Donation for Cancer Patients: Benefits, Risks, Justification.

Authors:  Silvio Nadalin; Lara Genedy; Alfred Königsrainer
Journal:  Recent Results Cancer Res       Date:  2021

2.  Live liver donors' information needs: A qualitative study of practical implications for informed consent.

Authors:  Elisa J Gordon; Jack Mullee; Anton Skaro; Talia Baker
Journal:  Surgery       Date:  2016-06-04       Impact factor: 3.982

3.  Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration.

Authors:  Muhammad H Raza; Whitney E Jackson; Angela Dell; Li Ding; James Shapiro; Elizabeth A Pomfret; Yuri Genyk; Linda Sher; Juliet Emamaullee
Journal:  Am J Transplant       Date:  2020-09-03       Impact factor: 8.086

4.  Living Kidney Donor Knowledge of Provided Information and Informed Consent: The PRINCE Study.

Authors:  Emerentia Q W Spoon; Kirsten Kortram; Sohal Y Ismail; Daan Nieboer; Frank C H d'Ancona; Maarten H L Christiaans; Ruth E Dam; Hendrik Sijbrand Hofker; Arjan W J Hoksbergen; Karlijn Ami van der Pant; Raechel J Toorop; Jacqueline van de Wetering; Jan N M Ijzermans; Frank J M F Dor
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

Review 5.  Should living donor liver transplantation be an option when deceased donation is not?

Authors:  Sarah R Lieber; Thomas D Schiano; Rosamond Rhodes
Journal:  J Hepatol       Date:  2017-11-01       Impact factor: 30.083

6.  Towards a standardised informed consent procedure for live donor nephrectomy: the PRINCE (Process of Informed Consent Evaluation) project-study protocol for a nationwide prospective cohort study.

Authors:  Kirsten Kortram; Emerentia Q W Spoon; Sohal Y Ismail; Frank C H d'Ancona; Maarten H L Christiaans; L W Ernest van Heurn; H Sijbrand Hofker; Arjan W J Hoksbergen; Jaap J Homan van der Heide; Mirza M Idu; Caspar W N Looman; S Azam Nurmohamed; Jan Ringers; Raechel J Toorop; Jacqueline van de Wetering; Jan N M Ijzermans; Frank J M F Dor
Journal:  BMJ Open       Date:  2016-04-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.